|
Volumn 17, Issue 3, 2000, Pages 169-175
|
Usage of diclofenac potassium (Cataflam®) when purchased as a non-prescription medicine in New Zealand
a a a a a |
Author keywords
Community pharmacies; New Zealand; Non prescription medicines; Post marketing surveillance; Rescheduled medicines
|
Indexed keywords
DICLOFENAC;
DICLOFENAC POTASSIUM;
NON PRESCRIPTION DRUG;
ARTICLE;
CONSUMER;
COST CONTROL;
DOSE RESPONSE;
DRUG USE;
GASTROINTESTINAL TOXICITY;
HEALTH SURVEY;
HOSPITAL PHARMACY;
HUMAN;
MYALGIA;
NEPHROTOXICITY;
NEW ZEALAND;
POSTMARKETING SURVEILLANCE;
PRESCRIPTION;
PURCHASING;
QUESTIONNAIRE;
TREATMENT CONTRAINDICATION;
|
EID: 0033711048
PISSN: 02810662
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (20)
|